We are live on ! Find out more
PLC

Peapod Lane Capital Portfolio holdings

AUM $148M
1-Year Est. Return 89.92%
This Fund
S&P 500
This Quarter Est. Return
-7.43%
1 Year Est. Return
+89.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$88.9M
AUM Growth
-$12M
Cap. Flow
+$2.84M
Cap. Flow %
3.19%
Top 10 Hldgs %
37.68%
Holding
72
New
15
Increased
33
Reduced
13
Closed
11

Top Buys

Rank Stock Value
1
PLRX icon
Pliant Therapeutics
PLRX
+$3.9M
2
TBI
Trueblue
TBI
+$1.78M
3
CLDT
Chatham Lodging
CLDT
+$1.54M
4
CRGX
CARGO Therapeutics
CRGX
+$1.47M
5
STHO icon
Star Holdings Shares of Beneficial Interest
STHO
+$1.36M

Top Sells

Rank Stock Value
1
VOXX
VOXX International Corporation Class A
VOXX
+$3.63M
2
MCS icon
Marcus Corp
MCS
+$3.26M
3
STRT icon
STRATTEC Security
STRT
+$2.93M
4
LAKE icon
Lakeland Industries
LAKE
+$2.02M
5
CMRX
Chimerix, Inc.
CMRX
+$1.85M

Sector Composition

Rank Sector Weight
1 Healthcare 27.75%
2 Consumer Discretionary 18.04%
3 Industrials 13.54%
4 Real Estate 11.34%
5 Consumer Staples 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORMP icon
51
Oramed Pharmaceuticals
ORMP
$179M
$540K 0.61%
252,224
+24,985
+11% +$57.6K
PMVP icon
52
PMV Pharmaceuticals
PMVP
$63.5M
$533K 0.6%
489,370
+43,626
+10% +$59.2K
KE
53
Kimball Electronics
KE
$628M
$519K 0.58%
+31,569
New +$558K
SCHL icon
54
Scholastic
SCHL
$792M
$505K 0.57%
+26,757
New +$535K
MGX icon
55
Metagenomi Therapeutics
MGX
$46.3M
$479K 0.54%
352,457
+1,244
+0.4% +$2.96K
KRON
56
DELISTED
Kronos Bio
KRON
$466K 0.52%
564,572
+1,952
+0.3% +$1.88K
WHWK
57
Whitehawk Therapeutics
WHWK
$271M
$430K 0.48%
241,403
-201,539
-46% -$526K
NKTR icon
58
Nektar Therapeutics
NKTR
$2.58B
$393K 0.44%
38,483
-35,351
-48% -$462K
IMA
59
ImageneBio Inc
IMA
$64.6M
$379K 0.43%
24,703
-17,619
-42% -$304K
KOD icon
60
Kodiak Sciences
KOD
$2.84B
$200K 0.23%
71,418
-95,425
-57% -$519K
NXTC icon
61
NextCure
NXTC
$26.7M
$127K 0.14%
22,120
-11,522
-34% -$102K
ACRS icon
62
Aclaris Therapeutics
ACRS
$869M
– –
-404,452
Closed -$1M
ASMB icon
63
Assembly Biosciences
ASMB
$529M
– –
-62,970
Closed -$994K
GIFI
64
DELISTED
Gulf Island Fabrication
GIFI
– –
-146,980
Closed -$1M
LAKE icon
65
Lakeland Industries
LAKE
$119M
– –
-78,964
Closed -$2.02M
MCS icon
66
Marcus Corp
MCS
$945M
– –
-151,531
Closed -$3.26M
NUVB icon
67
Nuvation Bio
NUVB
$2.32B
– –
-391,745
Closed -$1.04M
NXDT
68
NexPoint Diversified Real Estate Trust
NXDT
$238M
– –
-55,016
Closed -$332K
STRT icon
69
STRATTEC Security
STRT
$361M
– –
-71,214
Closed -$2.93M
VOXX
70
DELISTED
VOXX International Corporation Class A
VOXX
– –
-492,124
Closed -$3.63M
IVAC
71
DELISTED
Intevac Inc
IVAC
– –
-459,450
Closed -$1.56M
USAP
72
DELISTED
Universal Stainless & Alloy
USAP
– –
-28,792
Closed -$1.27M
1 2
3

Similar funds

AWA
Authentikos Wealth Advisory Morgan Hill, California $148M AUM 9.86% 1-Year Est. Return
OCM
Orleans Capital Management Mandeville, Louisiana $148M AUM 24.31% 1-Year Est. Return
CWMS
Cannon Wealth Management Services Winston Salem, North Carolina $148M AUM 13.37% 1-Year Est. Return
FFS
Flavin Financial Services Melbourne, Florida $149M AUM 14.79% 1-Year Est. Return
KCM
KM Capital Management Austin, Texas $149M AUM 18.7% 1-Year Est. Return
DAC
Dutch Asset Corp Selkirk, New York $149M AUM
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
RCM
Rockbridge Capital Management Alexandria, Virginia $149M AUM 1.06% 1-Year Est. Return

Peapod Lane Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Peapod Lane Capital held 72 positions worth $88.9M, down 12% from $101M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Peapod Lane Capital deployed $2.84M of net new capital in Q1 2025, opening 15 new positions and adding to 33 existing holdings. Its largest new stake was Pliant Therapeutics: 642,193 shares worth $867K.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Chimerix, Inc., an estimated $1.85M trimmed.

  • Peapod Lane Capital's largest Q1 2025 buy was Pliant Therapeutics: 642,193 shares worth $867K.
  • Peapod Lane Capital added most to Star Holdings Shares of Beneficial Interest in Q1 2025, an estimated $1.36M increase.
  • Peapod Lane Capital's biggest Q1 2025 reduction was Chimerix, Inc., cutting an estimated $1.85M.
  • Peapod Lane Capital fully exited VOXX International Corporation Class A in Q1 2025, selling an estimated $3.63M.
  • Peapod Lane Capital's ten largest holdings make up 38% of its $88.9M portfolio in Q1 2025.
  • Peapod Lane Capital opened 15 new positions and closed 11 in Q1 2025.
  • Peapod Lane Capital's portfolio value fell 12% quarter-over-quarter to $88.9M.

Based on Peapod Lane Capital's 13F filing for Q1 2025, filed 30 Apr 2025.